FDA Approves New HIV Drug Edurant
The FDA has approved Edurant (rilpivirine) for use in anti-HIV drug cocktails. Edurant is as effective as the popular Sustiva and is in the same NNRTI class of antiretroviral drugs.
Click here to read the full story.
No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.
The content has been reported and it will be reviewed by a moderator.
